Erythropoietin use and abuse

Bibliographic Details
Title: Erythropoietin use and abuse
Authors: M Joseph John, Vineeth Jaison, Kunal Jain, Naveen Kakkar, Jubbin J Jacob
Source: Indian Journal of Endocrinology and Metabolism, Vol 16, Iss 2, Pp 220-227 (2012)
Publisher Information: Wolters Kluwer Medknow Publications, 2012.
Publication Year: 2012
Collection: LCC:Diseases of the endocrine glands. Clinical endocrinology
LCC:Diseases of the digestive system. Gastroenterology
Subject Terms: Abuse, continuous erythropoietin receptor activator, darbepoetin, erythropoietin, Diseases of the endocrine glands. Clinical endocrinology, RC648-665, Diseases of the digestive system. Gastroenterology, RC799-869
More Details: Recombinant human erythropoietin (rhEPO) is arguably the most successful therapeutic application of recombinant DNA technology till date. It was isolated in 1977 and the gene decoded in 1985. Since then, it has found varied applications, especially in stimulating erythropoiesis in anemia due to chronic conditions like renal failure, myelodysplasia, infections like HIV, in prematurity, and in reducing peri-operative blood transfusions. The discovery of erythropoietin receptor (EPO-R) and its presence in non-erythroid cells has led to several areas of research. Various types of rhEPO are commercially available today with different dosage schedules and modes of delivery. Their efficacy in stimulating erythropoiesis is dose dependent and differs according to the patient′s disease and nutritional status. EPO should be used carefully according to guidelines as unsolicited use can result in serious adverse effects. Because of its capacity to improve oxygenation, it has been abused by athletes participating in endurance sports and detecting this has proved to be a challenge.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2230-8210
2230-9500
Relation: http://www.ijem.in/article.asp?issn=2230-8210;year=2012;volume=16;issue=2;spage=220;epage=227;aulast=John; https://doaj.org/toc/2230-8210; https://doaj.org/toc/2230-9500
DOI: 10.4103/2230-8210.93739
Access URL: https://doaj.org/article/7f133d4031654293b91873c8fd9dc26e
Accession Number: edsdoj.7f133d4031654293b91873c8fd9dc26e
Database: Directory of Open Access Journals
More Details
ISSN:22308210
22309500
DOI:10.4103/2230-8210.93739
Published in:Indian Journal of Endocrinology and Metabolism
Language:English